Surrey Heartlands

Joint Formulary & PAD

Azathioprine - Scleritis

You are here : Home > Formulary Search > Azathioprine - Scleritis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Oral suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :

Documentation

Shared Care
Shared Care Request letter (Specialist to Primary Care Prescriber) - National Shared Care - Appendix 1
Shared Care
Shared Care Agreement Letter (Primary Care Prescriber to Specialist)- National Shared Care - Appendix 2
Shared Care
Shared Care Refusal Letter (Primary Care Prescriber to Specialist)- National Shared Care - Appendix 3

PAD Profile

ChemicalSubstance :
Azathioprine
Indication :
Scleritis
Group Name :
Keywords :
RMOC, national shared care
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Azathioprine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Scleritis.

Committee Recommendations (1)

05 Oct 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)